Investor Relations
Profile
Business Description
The Nanōmix vision is to broadly impact health care delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote, or alternative settings, thus enabling faster clinical decision-making and potentially treatment-in-place.
Industry Classifications
Sector:
Healthcare
Industry:
Diagnostics
Sub-Industry:
Diagnostics Manufacturing
NAICS:
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC:
In Vitro and in Vivo Diagnostic Substances (2835) (28359907)